Abstract:A series of fifteen novel amide derivatives based on imidazo[1,2‐b]pyridazine scaffold were synthesized to yield good to excellentas lead compounds for antimicrobial activity. The molecular structures of the newly synthesized compounds were elucidated using spectroscopic techniques and supported by SXRD. These compounds were evaluated in vitro for antimicrobial activity against two Gram‐positive bacteria and two Gram‐negative bacteria. Some compounds exhibited significant antibacterial activity, which shown good correlation with In silco computational molecular docking study. A series of fifteen novel amide derivatives based on imidazo[1,2‐b]pyridazine scaffold were synthesized by taking imidazo[1,2‐b]pyridazine‐3‐carboxylic acid intermediates with respective substituted amines to yield good to excellent. The molecular structures of the newly synthesized compounds were elucidated using spectroscopic techniques (1H NMR, 13C NMR, and LCMS) and supported by single‐crystal X‐ray diffraction (SXRD) for the two compounds, 9 and 18. These compounds were evaluated in vitro for antimicrobial activity against two Gram‐positive bacteria (S. aureus and B. subtilis) and two Gram‐negative bacteria (E. coli and P. aeruginosa). Interestingly, compounds 10 and 16, displayed comparable antibacterial activity to the positive control (Tetracycline: 6.25 μg/mL) against Gram‐negative bacteria, particularly Pseudomonas aeruginosa, with a minimum inhibitory concentration (MIC) of 6.25 μg/mL. Compound 17 exhibited moderate antibacterial activity with an MIC of 10 μg/mL against the Gram‐positive bacterium Bacillus subtilis, whereas the positive control demonstrated an MIC of 6.25 μg/mL. These antibacterial activities were found to have a good correlation with Insilco computational molecular docking experiments using the receptor UDP‐N‐acetylglucosamine‐enolpyruvate reductase, Mtb MurB.

Synthesis of neamine–carboline conjugates for RNA binding and their antibacterial activities

Synthesis and biological evaluation of neamine analogues for RNA binding

Synthesis and Evaluation of Novel Neamine-Nucleoside Conjugates as Potential Antibiotic Targets for Escherichia coli 16S Ribosomal RNA

Synthesis and Biological Evaluation of Novel Neamine–nucleoside Conjugates Potentially Targeting to RNAs

Synthesis and Evaluation of Novel Neamine Derivatives Effectively Targeting to RNA

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Synthesis Of Neamine-Derived Pseudodisaccharides By Stereo- And Regio-Selective Functional Group Transformations

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Novel Potentially Antibacterial Naphthalimide-Derived Metronidazoles: Design, Synthesis, Biological Evaluation and Supramolecular Interactions with DNA, Human Serum Albumin and Topoisomerase II

Synthesis of Aminodisaccharide–nucleoside Conjugates for RNA Binding

Studies on the synthesis of neamine-dinucleosides and neamine-PNA conjugates and their interaction with RNA

Neamine-heterocycle Conjugates As Potential Anti-Hiv Agents

Synthesis of Imidazo[1,2‐b]pyridazine Scaffold Based Amide Derivatives as Potential Inhibitors for Bacterial Activity

Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles

Synthesis, antimicrobial activity, attenuation of aminoglycoside resistance in MRSA, and ribosomal A-site binding of pyrene-neomycin conjugates

Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives

Design, Synthesis and Structure-activity Relationships of Novel Non-ketolides: 9-Oxime Clarithromycin Featured with Seven- to Thirteen-atom-length Diamine Linkers at 3-OH

Synthesis and Antibacterial Activity of Novel Triazolo[4,3-a]pyrazine Derivatives

Design, Synthesis, and Bioassay of 5-Epi-aminoglycosides.

Synthesis and antibacterial activities of novel hybrid molecules based on benzothiazole, benzimidazole, benzoxazole, and pyrimidine derivatives, each connected to N -arylacetamide and benzoate groups

Membrane-Targeting Neolignan-Antimicrobial Peptide Mimic Conjugates to Combat Methicillin-Resistant Staphylococcus aureus (MRSA) Infections